Summit Therapeutics Inc (SMMT)

Jan 06, 2026

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - The Motley Fool

Jan 06, 2026

Jan 06, 2026

Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 06, 2026

Jan 04, 2026

Price-Driven Insight from (SMMT) for Rule-Based Strategy - Stock Traders Daily

Jan 04, 2026

Jan 04, 2026

Cantor Fitzgerald reaffirms overweight rating on Summit Therapeutics (SMMT) before key 2026 catalyst - MSN

Jan 04, 2026

Jan 02, 2026

Cantor Fitzgerald Reaffirms Overweight Rating on Summit Therapeutics (SMMT) Before Key 2026 Catalyst - Finviz

Jan 02, 2026

Dec 31, 2025

Summit Therapeutics Earnings Notes - Trefis

Dec 31, 2025

Dec 31, 2025

15 Best Stocks Under $25 to Buy Now - Insider Monkey

Dec 31, 2025

Dec 29, 2025

Farther Finance Advisors LLC Makes New $1.14 Million Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 29, 2025

Dec 28, 2025

Capricorn Fund Managers Ltd Takes $10.25 Million Position in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 28, 2025

Dec 24, 2025

Closing the Year With Gratitude and Shared Purpose – Summit Therapeutics - Oncodaily

Dec 24, 2025

Dec 21, 2025

Summit Therapeutics Shares Slip Following Mixed Results from Lung Cancer Trial - MSN

Dec 21, 2025

Dec 21, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 21, 2025

Dec 20, 2025

Is Summit Therapeutics Inc. stock a defensive play in 20252025 Price Momentum & Free Community Consensus Stock Picks - Улправда

Dec 20, 2025

Dec 20, 2025

How Summit Therapeutics Inc. stock compares to industry benchmarks2025 Big Picture & Long Hold Capital Preservation Plans - ulpravda.ru

Dec 20, 2025

Dec 20, 2025

Will Summit Therapeutics Inc. stock outperform Dow Jones indexPortfolio Return Report & AI Powered Buy and Sell Recommendations - ulpravda.ru

Dec 20, 2025

Dec 19, 2025

How Summit Therapeutics Inc. stock valuations compare to rivalsJuly 2025 Opening Moves & Community Verified Trade Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can Summit Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - Улправда

Dec 19, 2025

Dec 19, 2025

Summit Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Dec 19, 2025

Dec 19, 2025

Gap Down: How Summit Therapeutics Inc. stock valuations compare to rivalsWeekly Market Summary & Low Risk Profit Maximizing Plans - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Gains Recap: Will Summit Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Улправда

Dec 18, 2025

Dec 17, 2025

Barclays Upgrades Summit Therapeutics (SMMT) - Nasdaq

Dec 17, 2025

Dec 17, 2025

Barclays Upgrades SMMT, Raises Price Target to $18 | SMMT Stock News - GuruFocus

Dec 17, 2025

Dec 17, 2025

Summit Therapeutics (NASDAQ:SMMT) Upgraded by Barclays to Equal Weight Rating - MarketBeat

Dec 17, 2025

Dec 17, 2025

Summit Therapeutics stock rating upgraded by Barclays on BLA timeline - Investing.com UK

Dec 17, 2025

Dec 17, 2025

Summit Therapeutics (NASDAQ:SMMT) Stock Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat

Dec 17, 2025

Dec 13, 2025

Trading Systems Reacting to (SMMT) Volatility - news.stocktradersdaily.com

Dec 13, 2025

Dec 11, 2025

Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development - Yahoo Finance

Dec 11, 2025

Dec 11, 2025

Citi asserts buy rating on Summit Therapeutics Inc. (SMMT) on pipeline development - MSN

Dec 11, 2025

Dec 11, 2025

Has Summit Therapeutics Rally Left Enough Upside After 448.6% Surge and DCF Upswing? - Yahoo Finance

Dec 11, 2025

Dec 09, 2025

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run - Finviz

Dec 09, 2025

Dec 09, 2025

U.S. Markets Ended Tuesday Mixed As Galaxy Digital Led, Summit Therapeutics Lagged - Barron's

Dec 09, 2025

Dec 09, 2025

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility - ts2.tech

Dec 09, 2025

Dec 09, 2025

Summit Therapeutics (NASDAQ:SMMT) Shares Down 4.4%Here's Why - MarketBeat

Dec 09, 2025

Dec 08, 2025

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 08, 2025

Dec 07, 2025

New York State Common Retirement Fund Buys 227,513 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 07, 2025

Dec 06, 2025

Schroder Investment Management Group Sells 89,090 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025

Dec 06, 2025

State Board of Administration of Florida Retirement System Boosts Stake in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025

Dec 05, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 05, 2025

Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - Finviz

Dec 05, 2025

Dec 05, 2025

Why analysts upgrade Summit Therapeutics Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser

Dec 05, 2025

Dec 05, 2025

Summit Therapeutics Inc. (SMMT) Options Chain - Yahoo! Finance Canada

Dec 05, 2025

Dec 04, 2025

1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - AOL.com

Dec 04, 2025

Dec 04, 2025

Summit Therapeutics (NASDAQ:SMMT) Trading 9.2% HigherShould You Buy? - MarketBeat

Dec 04, 2025

Dec 04, 2025

Can Summit Therapeutics Inc. stock maintain operating marginsWeekly Gains Report & AI Powered Market Trend Analysis - Newser

Dec 04, 2025

Dec 03, 2025

Don't Buy Summit Therapeutics Until This Big Thing Happen - Nasdaq

Dec 03, 2025

Dec 02, 2025

Widening Q3 Losses and Insider Buying Might Change The Case For Investing In Summit Therapeutics (SMMT) - Yahoo Finance

Dec 02, 2025

Dec 02, 2025

Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Yahoo Finance

Dec 02, 2025

Dec 02, 2025

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Dec 02, 2025

Dec 02, 2025

SMMT: Four positive phase 3 trials and accelerated timelines position the pipeline for NSCLC market leadership - TradingView

Dec 02, 2025

Dec 02, 2025

XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 02, 2025